Thiopentone vs Propofol for Electroconvulsive Therapy
Thiopentone (thiopental) is the preferred induction agent for electroconvulsive therapy over propofol, as it produces longer seizure duration—a critical determinant of ECT efficacy—while maintaining acceptable hemodynamic profiles.
Guideline Recommendations
The American Academy of Child and Adolescent Psychiatry practice parameters identify methohexital as the standard anesthetic agent for ECT, with thiopental sodium listed as an acceptable alternative 1. Notably, propofol is not mentioned among the recommended agents in these guidelines, suggesting a preference hierarchy that favors barbiturates.
Evidence Supporting Thiopentone
Seizure Duration (Primary Efficacy Marker)
Multiple studies consistently demonstrate thiopentone's superiority in producing adequate seizure duration:
- Thiopentone produces significantly longer motor seizures (40.3±16.6 sec) compared to propofol (32±11.3 sec), p=0.001 2
- A 2018 study found thiopentone resulted in 35-second seizures versus only 11 seconds with propofol (p=0.046), with significantly more patients achieving motor convulsion activity (25 vs 13 patients, p=0.023) 3
- A 2016 Bayesian meta-analysis of 14 RCTs (610 participants) found methohexital (thiopentone's close barbiturate relative) significantly associated with higher seizure duration compared to propofol (p=0.018) 4
Clinical Efficacy
The evidence on depression outcomes shows conflicting results:
- One 2007 study found thiopentone associated with advantages in both efficacy and cognitive side effects compared to propofol 5
- However, a 2013 RCT (96 patients) found propofol produced lower post-treatment Hamilton Depression Rating Scale scores (10.7±1.8 vs 13.4±3.3) 6
- The 2016 meta-analysis found methohexital produced significantly more improved depression scores than propofol at 6 ECT sessions (p=0.001) 4
The weight of evidence, particularly the most recent systematic review, favors barbiturates for clinical efficacy.
Hemodynamic Considerations
Propofol's Cardiovascular Profile
Propofol provides more hemodynamic stability:
- Significantly lower systolic and diastolic blood pressure at all post-seizure time points 2
- Lower heart rate increases compared to thiopentone 2, 7
- FDA labeling warns propofol causes arterial hypotension (sometimes >30% decrease), with more pronounced effects than other IV induction agents 8
Clinical Implication
For patients with cardiovascular disease or uncontrolled hypertension, propofol may be preferred despite shorter seizure duration 2. However, for the general ECT population, the hemodynamic surge with thiopentone is typically well-tolerated and transient.
Practical Algorithm for Agent Selection
Use thiopentone as first-line for:
- Standard ECT patients without significant cardiovascular disease
- Patients requiring optimal seizure duration for treatment efficacy
- When seizure threshold is elevated or previous ECT sessions showed inadequate seizure duration
Consider propofol for:
- Patients with poorly controlled hypertension
- Significant coronary artery disease or recent myocardial infarction
- Cerebrovascular disease where blood pressure spikes pose risk
- When faster recovery and ambulation are priorities (propofol allows walking 10m at 20 minutes significantly better, p<0.0001) 7
Common Pitfalls
- Propofol causes significantly more injection pain (51.6% vs 1.6% of anesthetics with thiopentone) 7—consider lidocaine pretreatment
- Propofol's anticonvulsant properties are dose-dependent—using lower doses may partially mitigate seizure duration reduction, but this compromises anesthetic depth
- Longer apnea duration with propofol requires vigilant airway management 7
- The FDA warns that in elderly or hemodynamically unstable patients, propofol's rapid bolus administration should be avoided to minimize cardiorespiratory depression 8
Bottom Line
Thiopentone remains the superior choice for most ECT patients based on longer seizure duration, which directly correlates with treatment efficacy. The 2004 AACAP guidelines' explicit listing of thiopental as an acceptable alternative (while omitting propofol) 1, combined with consistent research showing longer seizures and the 2016 meta-analysis demonstrating better depression outcomes 4, establishes thiopentone as the evidence-based first choice. Reserve propofol for patients where cardiovascular stability outweighs the need for optimal seizure duration.